FDA Import Refusal SCS-8226406-2/11/1 — Merz Pharmaceuticals GmbH
The FDA refused shipment SCS-8226406-2/11/1 from Merz Pharmaceuticals GmbH (Germany) on Dec 6, 2021. The refused product falls under Drugs and Biologics — BOTOX. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 6, 2021
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 65QAY02 BOTOX
- Charges
- 75